SCYNEXIS, Inc. (SCYX)

USD 0.8

(-0.53%)

Total Assets Summary of SCYNEXIS, Inc.

  • SCYNEXIS, Inc.'s latest annual total assets in 2023 was 128.41 Million USD , up 46.24% from previous year.
  • SCYNEXIS, Inc.'s latest quarterly total assets in 2024 Q2 was 107.8 Million USD , down -8.84% from previous quarter.
  • SCYNEXIS, Inc. reported annual total assets of 87.81 Million USD in 2022, down -26.73% from previous year.
  • SCYNEXIS, Inc. reported annual total assets of 119.83 Million USD in 2021, up 16.87% from previous year.
  • SCYNEXIS, Inc. reported quarterly total assets of 107.8 Million USD for 2024 Q2, down -8.84% from previous quarter.
  • SCYNEXIS, Inc. reported quarterly total assets of 154.85 Million USD for 2023 Q2, up 120.29% from previous quarter.

Annual Total Assets Chart of SCYNEXIS, Inc. (2023 - 2012)

Historical Annual Total Assets of SCYNEXIS, Inc. (2023 - 2012)

Year Total Assets Total Assets Growth
2023 128.41 Million USD 46.24%
2022 87.81 Million USD -26.73%
2021 119.83 Million USD 16.87%
2020 102.53 Million USD 79.41%
2019 57.15 Million USD 7.49%
2018 53.17 Million USD 15.97%
2017 45.85 Million USD -23.32%
2016 59.79 Million USD 21.35%
2015 49.27 Million USD 24.2%
2014 39.67 Million USD 218.93%
2013 12.43 Million USD 2.65%
2012 12.11 Million USD 0.0%

Peer Total Assets Comparison of SCYNEXIS, Inc.

Name Total Assets Total Assets Difference
Journey Medical Corporation 76.84 Million USD -67.097%
ANI Pharmaceuticals, Inc. 904.42 Million USD 85.802%
Aquestive Therapeutics, Inc. 57.41 Million USD -123.644%
Pacira BioSciences, Inc. 1.57 Billion USD 91.844%
Sunshine Biopharma, Inc. 27.34 Million USD -369.566%
Sunshine Biopharma, Inc. 27.34 Million USD -369.566%
Safety Shot Inc 12.7 Million USD -910.388%
Alpha Teknova, Inc. 128.58 Million USD 0.136%
Collegium Pharmaceutical, Inc. 1.14 Billion USD 88.768%
Bright Green Corporation 17.4 Million USD -637.871%
Dynavax Technologies Corporation 997.09 Million USD 87.121%
Esperion Therapeutics, Inc. 205.79 Million USD 37.602%
Cosmos Health Inc. 66.29 Million USD -93.696%
PainReform Ltd. 9.93 Million USD -1193.172%
China SXT Pharmaceuticals, Inc. 23.12 Million USD -455.246%
Embecta Corp. 1.21 Billion USD 89.426%
Intra-Cellular Therapies, Inc. 728.29 Million USD 82.368%
Procaps Group, S.A. 460.18 Million USD 72.096%
Theratechnologies Inc. 77.76 Million USD -65.12%
Harrow Health, Inc. 311.75 Million USD 58.81%
Sonoma Pharmaceuticals, Inc. 14.89 Million USD -762.231%
Biofrontera Inc. 27.93 Million USD -359.731%
DURECT Corporation 45.18 Million USD -184.167%
Supernus Pharmaceuticals, Inc. 1.4 Billion USD 90.886%
Cronos Group Inc. 1.13 Billion USD 88.679%
OptiNose, Inc. 107.72 Million USD -19.199%
Ironwood Pharmaceuticals, Inc. 471.07 Million USD 72.741%
Kala Pharmaceuticals, Inc. 55.94 Million USD -129.516%
RedHill Biopharma Ltd. 23.04 Million USD -457.171%
Organogenesis Holdings Inc. 460.02 Million USD 72.086%
Guardion Health Sciences, Inc. 11.91 Million USD -977.447%
Cumberland Pharmaceuticals Inc. 81.77 Million USD -57.029%
Radius Health, Inc. 1.71 Billion USD 92.517%
Universe Pharmaceuticals INC 53.28 Million USD -140.982%
ProPhase Labs, Inc. 91.92 Million USD -39.689%
Phibro Animal Health Corporation 982.18 Million USD 86.926%
Procaps Group S.A. 460.18 Million USD 72.096%
Alvotech 950.09 Million USD 86.484%
TherapeuticsMD, Inc. 43.3 Million USD -196.502%
Viatris Inc. 47.68 Billion USD 99.731%
Rockwell Medical, Inc. 52.17 Million USD -146.127%
Aytu BioPharma, Inc. 118.09 Million USD -8.736%
SIGA Technologies, Inc. 254.83 Million USD 49.61%
Tilray Brands, Inc. 4.33 Billion USD 97.038%
Lifecore Biomedical, Inc. 273.7 Million USD 53.083%
Shineco, Inc. 84.17 Million USD -52.546%
PetIQ, Inc. 868.22 Million USD 85.21%
Regencell Bioscience Holdings Limited 8.43 Million USD -1421.792%
Incannex Healthcare Limited 17.04 Million USD -653.282%
Neurocrine Biosciences, Inc. 3.25 Billion USD 96.051%
Alimera Sciences, Inc. 153.52 Million USD 16.357%
Silver Spike Investment Corp. 88.57 Million USD -44.973%
Assertio Holdings, Inc. 286.41 Million USD 55.166%
Shuttle Pharmaceuticals Holdings, Inc. 5.95 Million USD -2057.555%
Petros Pharmaceuticals, Inc. 33.79 Million USD -279.964%
Clever Leaves Holdings Inc. 31.24 Million USD -311.01%
Cyclo Therapeutics, Inc. 13.24 Million USD -869.327%
Avadel Pharmaceuticals plc 261.12 Million USD 50.824%
Hempacco Co., Inc. 18.04 Million USD -611.697%
Talphera, Inc. 20.39 Million USD -529.625%
Alvotech 950.09 Million USD 86.484%
Eagle Pharmaceuticals, Inc. 406.16 Million USD 68.384%
Lantheus Holdings, Inc. 1.65 Billion USD 92.223%
Currenc Group, Inc. 141.49 Million USD 9.243%
Kamada Ltd. 351.96 Million USD 63.516%
Indivior PLC 1.95 Billion USD 93.419%
Evoke Pharma, Inc. 7.06 Million USD -1716.668%
Flora Growth Corp. 23.62 Million USD -443.52%
Cyclo Therapeutics, Inc. 13.24 Million USD -869.327%
Evolus, Inc. 188.99 Million USD 32.056%
HUTCHMED (China) Limited 1.27 Billion USD 89.966%
Amphastar Pharmaceuticals, Inc. 1.51 Billion USD 91.512%
Akanda Corp. 8.83 Million USD -1352.626%